Gastroretentive drug delivery system of carbamazepine: Formulation optimization using simplex lattice design: A technical note

AAPS PharmSciTech

Volumn 8, Issue 1, 2007, Pages

  Patel, Dasharath M ^a   Patel, Natvarlal M ^a   Pandya, Nitesh N ^a   Jogani, Pranav D ^b  

^a Shri B M Shah College of Pharmacy Modasa   (India)

^b ZYDUS RESEARCH CENTRE   (India)

Author keywords

Carbamazepine; Floating; Gastroretentive; Melt granulation; Simplex lattice design

Indexed keywords

BICARBONATE; CARBAMAZEPINE; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; ANTICONVULSIVE AGENT; BIOMIMETIC MATERIAL; DRUG CARRIER;

ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG RELEASE; DRUG RETENTION; DRUG SOLUBILITY; DRUG STABILITY; FLOTATION; GASTROINTESTINAL TRACT; IN VITRO STUDY; MULTIPLE REGRESSION; PROCESS OPTIMIZATION; TABLET FORMULATION; TEMPERATURE DEPENDENCE; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG FORMULATION; DRUG SCREENING; EVALUATION; MATERIALS TESTING; METHODOLOGY; STOMACH JUICE; TABLET;

ANTICONVULSANTS; BIOMIMETIC MATERIALS; CARBAMAZEPINE; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; GASTROINTESTINAL CONTENTS; MATERIALS TESTING; TABLETS;

EID: 33847698233     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt0801001     Document Type: Article

References (22)

1. Colombo P, Bettini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: gel layer behavior, mechanism and optimal performance. Pharm Sci Technolo Today. 2000;3:198-204.
2. Baumgartner S, Kristi J, Vrecer F, Vodopivec P, Zorko B. Optimization of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm. 2000;195:125-135.
3. Iannuccelli V, Coppi G, Bernabei MT, Cameroni R. Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. Int J Pharm. 1998;174:47-54.
4. Santus G, Lazzarini G, Bottoni G, et al. An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations. Eur J Pharm Biopharm. 1997;44:39-52.
5. Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm. 1996;22:531-540.
6. Deshpande AA, Shah NH, Rhodes CT, Malick W. Development of a novel controlled-release system for gastric retention. Pharm Res. 1997;14:815-819.
7. Menon A, Ritschel WA, Sakr A. Development and evaluation of a monolithic floating dosage form for furosemide. J Pharm Sci. 1994;83:239-245.
8. Whitehead L, Fell JT, Collett JH, Sharma HL, Smith AM. Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J Control Release. 1998;55:3-12.
9. Singh B, Kim K. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release. 2000;63:235-259.
10. Chawla G, Bansal A. A means to address regional variability in intestinal drug absorption. Pharm Technol. 2003;27:50-68.
11. Rosa M, Zia H, Rhodes T. Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm. 1994;105:65-70.
12. Lachman L, Lieberman H, Kanig J. The Theory and Practice of Industrial Pharmacy. 3rd ed. Philadelphia, PA: Lei & Feiberger; 1970:283.
13. Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci. 1969;58:1253-1257.
14. Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145-1149.
15. Hixon AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem. 1931;23:923-931.
16. Korsmeyer R, Gurny R, Peppas N. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15: 25-35.
17. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110-111.
18. Harland RS, Gazzaniga A, Sangalli ME, Colombo P, Peppas NA. Drug/polymer matrix: swelling and dissolution. Pharm Res. 1988;5:488-494.
19. Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmacol. 1972;24:979-981.
20. Goldsmith JA, Randall N, Ross SD. Methods of expressing dissolution rate data. J Pharm Pharmacol. 1978;30:347-349.
21. Romero P, Costa JB, Chulia D, eds. Statistical optimization of a controlled release formulation obtained by a double compression process: application of a Handmard matrix and factorial design. In: Wells JI, Rubinstein MH, Horwood E, eds. Pharmaceutical Technology, Controlled Drug Release. vol. 2. New York, NY: Ellis Horwood; 1991:44-58.
22. Bamba M, Puisieux F. Release mechanisms in gel forming sustained release preparation. Int J Pharm. 1979;2:307-315.